
TAXA Biotechnologies YC Application
TAXA Biotechnologies went through Y Combinator in the Summer 2014 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.
- YC batch
- Summer 2014
- Industry
- HealthcareConsumer Health and Wellness
- Team size
- 2
- Status
- Inactive
- Launched
- 2014
Founders
Antony EvansFounder/CEO
What TAXA Biotechnologies does
The TAXA platform has been specifically designed to enable anyone to perform metabolic engineering of plants without stepping into a lab. We provide access to protein engineering, DNA assembly, transient experiments and stable transformation as a service. The best thing is that anything "Powered by TAXA" is designed to be free from expensive regulatory approval, meaning the products are available for sale or distribution to consumers in the United States immediately after they are developed. For a detailed list of the experiments which can be run on our platform please see the Services page. Our vision is a world where bio-engineering is as easy and commonplace as mobile application development is today. Game-changing technologies, like genetic engineering, should not be the exclusive preserve of large corporations and a wealthy elite. Democratizing the tools of creation enables anyone, anywhere, to genetically engineer plants and will unleash a wave of creativity to power an environment where ultimately what we create is limited only by our imagination. The TAXA platform is our next step in the realization of that dream We are also the team behind the first synthetic biology crowdfunding project, raising $484k on Kickstarter to make real glowing plants:
TAXA Biotechnologies's YC application, reconstructed
Y Combinator application
TAXA Biotechnologies, Summer 2014 batch. The real form questions, answered from public data.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
TAXA Biotechnologies
Cheaper, faster, better genetic engineering of plants
We built the TAXA platform to let anyone perform metabolic engineering on plants without needing a lab. It offers protein engineering, DNA assembly, transient experiments, and stable transformation as services. Our platform is unique because anything created with it is designed to be free from costly regulatory approval, so products can reach customers in the US immediately after development.
We live in San Francisco, CA and plan for the company to remain based here after YC.
San Francisco is where we are based because it offers access to biotech talent and a strong startup ecosystem connected to healthcare and genetic engineering.
21 more answers in the full application
Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.
Frequently Asked Questions
Is this the real TAXA Biotechnologies YC application?
No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from TAXA Biotechnologies's public data (launch notes, founder backgrounds, product description). It shows how a company like TAXA Biotechnologies would present itself to YC, not the text they submitted.
What YC batch was TAXA Biotechnologies in?
TAXA Biotechnologies was part of the Y Combinator Summer 2014 batch.
Who founded TAXA Biotechnologies?
TAXA Biotechnologies was founded by Antony Evans.
What does TAXA Biotechnologies do?
We enable cheaper, faster, and better genetic engineering of plants.…
How do I read the full reconstructed application?
Create a free Round Funded account. The full 26-answer version of TAXA Biotechnologies's application, and every other YC batch, is in YC Insights.